Literature DB >> 8021969

Characteristics of HIV-1 gp120 glycoprotein binding to glycolipids.

T McAlarney1, S Apostolski, S Lederman, N Latov.   

Abstract

We examined the binding of the gp120 envelope glycoprotein (gp120) of the human immunodeficiency virus (HIV-1) to sulfatide (GalS), galactocerebroside (GalC), and GM1-ganglioside (GM1). The gp120 glycoprotein bound to GalS but not to GalC or GM1 by enzyme-linked immunosorbent assay (ELISA) and by an immunospot assay on nitrocellulose paper. However, it bound to all three glycolipids by an immunospot assay on thin layer chromatography (TLC) plates. In studies to determine whether GalS could be a receptor for gp120 on the surface of cells, gp120 bound to GalS incorporated into the plasma membrane of lymphoid cells as determined by cytofluorometric analysis and immunofluorescence microscopy. These studies indicate that GalS may function as a receptor for gp120 and HIV-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021969     DOI: 10.1002/jnr.490370404

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Charged membrane surfaces impede the protein-mediated transfer of glycosphingolipids between phospholipid bilayers.

Authors:  P Mattjus; H M Pike; J G Molotkovsky; R E Brown
Journal:  Biochemistry       Date:  2000-02-08       Impact factor: 3.162

2.  Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide.

Authors:  S Moses Dennison; Kara M Anasti; Frederick H Jaeger; Shelley M Stewart; Justin Pollara; Pinghuang Liu; Erika L Kunz; Ruijun Zhang; Nathan Vandergrift; Sallie Permar; Guido Ferrari; Georgia D Tomaras; Mattia Bonsignori; Nelson L Michael; Jerome H Kim; Jaranit Kaewkungwal; Sorachai Nitayaphan; Punnee Pitisuttithum; Supachai Rerks-Ngarm; Hua-Xin Liao; Barton F Haynes; S Munir Alam
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Synthesis of non-hydroxy-galactosylceramides and galactosyldiglycerides by hydroxy-ceramide galactosyltransferase.

Authors:  P van der Bijl; G J Strous; M Lopes-Cardozo; J Thomas-Oates; G van Meer
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

4.  Conformation of sulfoquinovosyldiacylglycerol bound to a magnetically oriented membrane system.

Authors:  K P Howard; J H Prestegard
Journal:  Biophys J       Date:  1996-11       Impact factor: 4.033

5.  Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120.

Authors:  Y Furuta; K Eriksson; B Svennerholm; P Fredman; P Horal; S Jeansson; A Vahlne; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line.

Authors:  N Yahi; J M Sabatier; S Baghdiguian; F Gonzalez-Scarano; J Fantini
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  Macrophages transmit human immunodeficiency virus type 1 products to CD4-negative cells: involvement of matrix metalloproteinase 9.

Authors:  Claudia Muratori; Antonella Sistigu; Eliana Ruggiero; Mario Falchi; Ilaria Bacigalupo; Clelia Palladino; Elena Toschi; Maurizio Federico
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.